What’s new

  • ESPE welcomes new CEO, Dr Kay Miller

    We are delighted to announce that Dr. Kay Miller, FCMI, CMgr has been appointed as ESPE Chief Executive Officer. Her leadership and expertise mark an exciting […]

    Read more

  • ESPE joins the European Society of Endocrinology and the Endocrine Society in a coordinated call on the EU 27 Member States to step up their ambition in tackling PFAS and other Endocrine Disrupting Chemicals

    The European and global endocrine community are disseminating an open letter to the EU27 Member States with the help of national paediatric and adult endocrine societies. […]

    Read more

  • President update, June 2025

    We are deeply saddened by the ongoing conflicts affecting communities around the world. Our thoughts are with all those impacted, and we stand in solidarity with […]

    Read more

  • President update, May 2025

    I would like to begin this month’s President’s update by saying thank you to everyone who joined us at the first ever Joint Congress of ESPE […]

    Read more

  • Backgrounder: EDCs and Children

    The ESPE EU Committee has developed a ‘backgrounder’ on the effects of Endocrine Disrupting Chemicals (EDCs) and children. The document will be used for different ESPE […]

    Read more

  • President update, April 2025

    We are less than two weeks away from the highly anticipated Joint Congress of ESPE and ESE 2025! If you have registered to join us on […]

    Read more

Upcoming events

News alert

Sign up for our monthly news alert!